Cargando…
Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells
Acute myeloid leukemias (AMLs) with a rearrangement of the mixed-linage leukemia (MLL) gene are aggressive hematopoietic malignancies. Here, we explored the feasibility of using the H3K9- and H3K36-specific demethylases Jmjd2/Kdm4 as putative drug targets in MLL-AF9 translocated leukemia. Using Jmjd...
Autores principales: | Agger, Karl, Miyagi, Satoru, Pedersen, Marianne Terndrup, Kooistra, Susanne M., Johansen, Jens Vilstrup, Helin, Kristian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911927/ https://www.ncbi.nlm.nih.gov/pubmed/27257215 http://dx.doi.org/10.1101/gad.280495.116 |
Ejemplares similares
-
The Histone Lysine Demethylase JMJD3/KDM6B Is Recruited to p53 Bound Promoters and Enhancer Elements in a p53 Dependent Manner
por: Williams, Kristine, et al.
Publicado: (2014) -
Heme promotes transcriptional and demethylase activities of Gis1, a member of the histone demethylase JMJD2/KDM4 family
por: Lal, Sneha, et al.
Publicado: (2018) -
Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia
por: Li, Yunan, et al.
Publicado: (2018) -
The Lysine Demethylase KDM5B Regulates Islet Function and Glucose Homeostasis
por: Backe, Marie Balslev, et al.
Publicado: (2019) -
Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3
por: Sherry-Lynes, Maureen M., et al.
Publicado: (2017)